Incyte logo

INCY - Incyte News Story

$83.79 1.5  1.8%

Last Trade - 2:56pm

Sector
Healthcare
Size
Large Cap
Market Cap £13.04bn
Enterprise Value £11.65bn
Revenue £1.95bn
Position in Universe 638th / 6854

BRIEF-Incyte Announces European Commission Approval Of Pemazyre (pemigatinib)

Mon 29th March, 2021 6:50pm
March 29 (Reuters) - Incyte Corp  INCY.O :
    * INCYTE ANNOUNCES EUROPEAN COMMISSION APPROVAL OF PEMAZYRE®
(PEMIGATINIB) AS A TREATMENT FOR ADULTS WITH LOCALLY ADVANCED OR
METASTATIC CHOLANGIOCARCINOMA WITH A FIBROBLAST GROWTH FACTOR
RECEPTOR 2 (FGFR2) FUSION OR REARRANGEMENT

Source text for Eikon:  urn:newsml:reuters.com:*:nBw5PDw53a
Further company coverage:  INCY.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.